» Authors » O Keiser

O Keiser

Explore the profile of O Keiser including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 407
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Keiser O, Giudici F, Mullhaupt B, Junker C, Dufour J, Moradpour D, et al.
J Viral Hepat . 2017 Nov; 25(2):152-160. PMID: 29159841
In order to accurately assess the burden of hepatitis C (HCV) and develop effective interventions, we must understand the magnitude and trends of mortality related to the disease. In the...
2.
Salazar-Vizcaya L, Kouyos R, Fehr J, Braun D, Estill J, Bernasconi E, et al.
J Viral Hepat . 2017 Jul; 25(1):10-18. PMID: 28685917
Increasing access to direct-acting antiviral (DAA) treatment for hepatitis C virus (HCV) infection and decelerating the rise in high-risk behaviour over the next decade could curb the HCV epidemic among...
3.
Giudici F, Bertisch B, Negro F, Stirnimann G, Mullhaupt B, Moradpour D, et al.
J Viral Hepat . 2016 Mar; 23(9):697-707. PMID: 27006320
Socio-demographic and behavioural characteristics are associated with delayed diagnosis and disease progression in HCV-infected persons. However, many analyses focused on single variables rather than groups defined by several variables. We...
4.
Scherrer A, von Wyl V, Yang W, Kouyos R, Boni J, Yerly S, et al.
Clin Infect Dis . 2016 Mar; 62(10):1310-1317. PMID: 26962075
Background: Drug resistance is a major barrier to successful antiretroviral treatment (ART). Therefore, it is important to monitor time trends at a population level. Methods: We included 11 084 ART-experienced...
5.
Marzel A, Shilaih M, Yang W, Boni J, Yerly S, Klimkait T, et al.
Clin Infect Dis . 2015 Sep; 62(1):115-122. PMID: 26387084
Background: Reducing the fraction of transmissions during recent human immunodeficiency virus (HIV) infection is essential for the population-level success of "treatment as prevention". Methods: A phylogenetic tree was constructed with...
6.
Hasse B, Tarr P, Marques-Vidal P, Waeber G, Preisig M, Mooser V, et al.
Open Forum Infect Dis . 2015 Aug; 2(3):ofv108. PMID: 26284258
Background.  Although acquired immune deficiency syndrome-associated morbidity has diminished due to excellent viral control, multimorbidity may be increasing among human immunodeficiency virus (HIV)-infected persons compared with the general population. Methods.  ...
7.
Kouyos R, Hasse B, Calmy A, Cavassini M, Furrer H, Stockle M, et al.
Open Forum Infect Dis . 2015 Jul; 2(2):ofv077. PMID: 26180827
Condomless sex is a key driver of sexually transmitted diseases. In this study, we assess the long-term changes (2000-2013) of the occurrence of condomless sex among human immunodeficiency virus (HIV)-infected...
8.
Wandeler G, Schlauri M, Jaquier M, Rohrbach J, Metzner K, Fehr J, et al.
Open Forum Infect Dis . 2015 Jun; 2(1):ofv026. PMID: 26034775
Background.  The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with human immunodeficiency virus (HIV). We aimed to describe changes in treatment uptake and outcomes of incident...
9.
Hasse B, Iff M, Ledergerber B, Calmy A, Schmid P, Hauser C, et al.
Open Forum Infect Dis . 2015 Mar; 1(2):ofu040. PMID: 25734114
Background: The factors that contribute to increasing obesity rates in human immunodeficiency virus (HIV)-positive persons and to body mass index (BMI) increase that typically occurs after starting antiretroviral therapy (ART)...
10.
Feldacker C, Tweya H, Keiser O, Weigel R, Kalulu M, Fenner L, et al.
Trop Med Int Health . 2012 Jul; 17(9):1108-16. PMID: 22808948
Objectives: To describe initial registration characteristics of adult and paediatric TB patients at a large, public, integrated TB and HIV clinic in Lilongwe, Malawi, between January 2008 and December 2010....